United States· US:23155-866_5cc5ceff-77b9-40d2-bba6-0d4af992e3f8
GABAPENTIN
A gabapentin product containing gabapentin, registered in United States by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Gabapentin is registered in 16 of 19 countries.
Countries holding a registration under ATC N02BF01 (gabapentin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Gabapentin · ATC N02BF01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of gabapentin costs, country by country.
Normalised to the WHO defined daily dose (1.8 g), the median price runs from $0.19 in United States to $3.62 in Switzerland — a ×19 gap.
- United States: $0.19 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Gabapentin · price per daily dose (1.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.62
- IT Italy$2.46
- US United States$0.19 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GABAPENTIN
- Manufacturer
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- N02BF01
- ATC class
- Gabapentin
- Defined daily dose
- 1.8 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc112315586601100 CAPSULE in 1 BOTTLE (23155-866-01)
- ndc112315586605500 CAPSULE in 1 BOTTLE (23155-866-05)
- ndc1123155-866-01
- ndc1123155-866-05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
298 interactions on record for gabapentin.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gabapentin · interactions on record
298 records
- 4 severe
- 47 moderate
- 10 minor
- 237 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gabapentin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGABAGAMMAWörwag Pharma GmbH & Co. KG, Böblingen
- United KingdomGabapentin 100mg capsulesCrescent Pharma Ltd
- ItalyGABAPENTIN ABCICE S.P.A.
- FinlandGabapentin - 1 A Pharma
- FranceGABAPENTINE ARROW GENERIQUES 100 mg, géluleARROW GENERIQUES
- SwitzerlandGabapentin Sandoz eco
- CanadaAPO-GABAPENTINAPOTEX INC
- NetherlandsGabapentine Accord 100 mg, harde capsulesAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Gabadal, Gabapentin !@ctavis
- Belgium · Gabapentin Sandoz, Gabapentine Eg
- Bulgaria · Габагамма, Gabagamma, Неуронтин
- Cyprus · Gabantin, Gabapentin Accord
- Czechia · Gabagamma, Gabanox
- Germany · Gabagamma, Gabaliquid Geriasan
- Denmark · Gabamed, Gabapenstad
- Estonia · Gabagamma, Gabapentin Accord
- Spain · Gabapentin Strides, Gabapentina Almus
- Finland · Gabapentin Accord, Gabapentin Actavis
- France · Gabapentin Teva, Gabapentine Arrow Generiques
- United Kingdom (Northern Ireland) · Gabapentin, Gabapentin Accord
- Greece · Elpichoc, Gabantin
- Croatia · Katena, Neurontin
- Hungary · Gabagamma, Garonoan
- Ireland · Gabapentin Accord, Gabapentin Accord Healthcare Ireland
- Iceland · Gabagen, Gabapentin Pcd
- Italy · Gabapentin Abc, Gabapentin Almus
- Lithuania · Gabagamma, Gabapentin Accord
- Luxembourg · Gabapentine Eg, Neurontin
- Latvia · Gabagamma, Gabapentin Aurobindo
- Malta · Gabapentin Ascend, Gabapentin Aurobindo
- Netherlands · Gabapentin Aurobindo, Gabapentine Accord
- Norway · Gabapentin Strides, Gabapentin Teva
- Poland · Epigapent, Gabapentin Aurovitas
- Portugal · Gabamox, Gabapentin Ratiopharm
- Romania · Gabagamma, Gabalept
- Sweden · Gabapentin 1a Farma, Gabapentin Accord
- Slovenia · Neurontin
- Slovakia · Gabagamma, Gabapentin Glenmark
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d750a00f-04ba-41f2-ae78-bbf3818fb2db GET /v1/drugs/d750a00f-04ba-41f2-ae78-bbf3818fb2db?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "GABAPENTIN",
"productndc": "23155-866",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA211314",
"marketing_category": "ANDA"
}See everything about gabapentin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.